We recently mapped Adip1 , an obesity quantitative trait locus (QTL), to the middle portion of mouse chromosome 1, between microsatellite markers D1Mit10 (92,584,545 bp) and D1Mit139 (128,413,910 bp) in a set of LGXSM recombinant inbred (RI) strains ( 1, 2 ). This same region was found to affect body size at necropsy and body size growth between 3 and 10 weeks of age in replicate F 2 intercrosses of LG/J with SM/J mice ( 3, 4 ), the parent strains of the LGXSM RI strain set. In the RI line mapping study, this region was found to have signifi cant effects on all four measured fat depots (reproductive, renal, mesenteric, and inguinal), body weight at necropsy, and serum leptin and cholesterol levels. These effects were observed in both sexes and on both high and low fat diets. The calpain-10 locus ( Capn10, Chromosome 1 begins at 94,830,953 bp) is one of 134 genes identifi ed in this QTL region ( 1 ).
MATERIALS AND METHODS
LG/J and SM/J are inbred strains selected for large or small body weight at 60 days ( 26 ) and have been used for a series of QTL mapping studies for body size, growth, obesity-and diabetesrelated traits, and skeletal morphology ( 2, (27) (28) (29) . Phenotypic differences between these two strains are typically caused by many genes of relatively small effect ( 1, 26 ) . Adip1 , one such QTL, is mapped to the central section of mouse chromosome 1, which contains the positional candidate gene Capn10 ( 1 ) .
The Capn10 knockout mice were generated by replacing exons 1 and 2 with a selective cassette (nuclear-localized LacZ and neomycin-resistance genes) in R1 embryonic stem (ES) cells which were derived from a male blastocyst, hybrid of two 129 substrains (129 × 1/SvJ and 129S1/Sv-Oca2 + Tyr + Kitl Sl-J /J ). Heterozygous Capn10 knockout mice were backcrossed to C57BL/6J for six generations. The region of chromosome 1 between markers rs13475881 (nt 58,439,402) and rs6194543 (nt 157,588,922) is still 129 in origin.
LG/J and SM/J mice were obtained from Jackson Laboratories and bred to produce parents for the QHCT crosses. C57BL/6J wild-type mice were obtained from the Jackson Laboratories.
LG/J and SM/J males were bred to Capn10 knockout (mutant) and C57BL/6J (wild-type) females to produce four different sets of hybrid offspring: LG/J × Capn10 knock-out (N = 116; 67♀:49♂);
LG/J × C57BL/6J wild-type (N = 76; 38♀:38♂); SM/J × Capn10 knock-out (N = 64; 33♀:31♂); and SM/J × C57BL/6J wild-type (N = 79; 41♀:38♂). Each animal's body weight was recorded weekly from 1 to 20 weeks. Pups were weaned at 3 weeks of age, transferred to single-sex cages of four or fi ve animals, placed on a high-fat diet (Harlan Teklad #TD88137; Table 1 ), and maintained to 21 weeks of age. An intraperitoneal glucose tolerance test (IPGTT) was performed in week 19 by testing basal glucose level using a Glucometer Dex blood glucose meter (Bayer) after a 4-h fast, injecting 0.01 ml of a 10% glucose solution for each gram of body weight, and measuring subsequent glucose levels 15, 30, 60, and 120 min postinjection. From these measurements, the area under the curve (AUC) of glucose level plotted against time since injection was calculated for each animal. An insulin response test (IRT) was performed in week 20 by fi rst measuring fasting (4-h fast) glucose level, then injecting 0.75 U of insulin per kg body weight into the peritoneum, and testing glucose levels at 15, 30, 60, and 120 min after injection. Animals experiencing insulin shock as denoted by severe ataxia, extreme lethargy, and glucose readings at or below 25 mg/dl were immediately injected with 0.25 cc of 10% glucose. All postinjection data for insulin shock animals were excluded from analysis. All procedures were consistent with the PHS Policy on Humane Care and Use of Laboratory Animals and approved by Washington University School of Medicine's Animal Studies Committee.
Animals were sacrifi ced using an overdose of sodium pentobarbital at 21 weeks of age after a 4-h fast, followed by blood collection via cardiac puncture. Serum levels of cholesterol, triglycerides (TG), free fatty acids, glucose, insulin, and leptin were assayed as described in Chakravarthy et al. ( 30 ) . Body weight was recorded at necropsy and internal organs (heart, liver, kidneys, spleen) and fat depots (reproductive, renal, inguinal, mesenteric) were removed and weighed to the nearest 0.01 g.
A three-way ANOVA, including sex, experimental strain, tester strain, and their interactions as factors ( 31 ) was performed for each trait. Sets of traits were also analyzed jointly using MANOVA, including the fat depots, body and organ weights, time-specifi c glucose values for the IPGTT and IRT tests, and serum levels. When a signifi cant three-way sex-by-experimental strain-by-tester strain interaction was detected, analyses of the strain types and their interaction were performed separately in males and females. related phenotypes, although replication of results across populations has proven diffi cult. The calpain-10 gene is also a very good candidate for being the locus responsible for Adip1 , the obesity-related QTL.
Here, we test the hypothesis that Capn10 is responsible for the observed QTL effects in populations derived from the LG/J-by-SM/J cross using a quantitative hybrid complementation test (QHCT) ( 20 ) . This test has been successfully applied in QTL studies in Drosophila ( 21, 22 ) , Arabidopsis ( 23 ) , and mice ( 24, 25 ) . This is not the same as an ordinary complementation test, but it has a similar interpretation. In a QHCT, two experimental strains (LG/J and SM/J) are each crossed with two tester strains, a mutant strain ( Capn10 Ϫ / Ϫ ) and its wild-type control (C57BL/6J). If the mutant-wild-type contrast is significantly different for crosses involving the two experimental strains, then there is a quantitative failure of the mutant to complement the experimental strain alleles. Quantitative failure to complement is indicated by a signifi cant experimental-by-tester strain interaction among the four classes of hybrids ( Fig. 1 ) . A quantitative failure to complement signifi es either that the QTL alleles at the locus of interest are responsible for the observed phenotypic variation or that other loci differing between the experimental strains interact with the mutant allele. In either case, the locus of interest is confi rmed as being involved in trait variation.
Here we cross experimental mouse strains LG/J and SM/J with a Capn10 knock-out strain ( Capn10
) (H. Ye and G. I. Bell, unpublished observations) and its C57BL/6J wildtype control strain to test whether the Capn10 gene may be responsible for the observed LG/J-by-SM/J intercross QTL effects. ( 20 ) . Two experimental strains (LG/J and SM/J) are crossed to two tester strains ( Capn10 knockout and C57BL/6J wild-type) producing four sets of F 1 hybrids. When the difference between the mutant and wild-type hybrids changes, depending on the experimental strain they are mated to, there is a quantitative failure to complement as a result of differences between experimental strain alleles at the mutant locus or at other loci interacting with the mutant locus. The signifi cance of failure to complement is given by the experimental-by-tester strain interaction. for fat pads, body, and organ weights. Serum cholesterol failed to show a signifi cant experimental-by-tester strain interaction, although the Capn10 knockout hybrid animals had consistently lower cholesterol levels than wild-type hybrids.
A three-way MANOVA with experimental strain, tester strain, and sex showed a signifi cant three-way interaction indicating that the results of the QHCT differed between males and females for glucose response curves from the IPGTT (Probability = 3.1 × 10
). Therefore, we performed the test separately in males and females ( Fig. 3 ). Males showed a very strong experimental-by-tester strain interaction. However, unlike the fat pads and organ weights, it is the SM/J hybrids, not the LG/J ones, that show the effect of the Capn10 knockout. The difference between knockout and wild-type hybrids is not signifi cant when they are mated to the LG/J strain. However, there is a large difference between knockout and wild-type hybrids when crossed to the SM/J strain. The SM/J-by-Capn10 knockout males have much lower glucose levels (27% lower at the baseline, and 26% to 40% lower through the rest of the 2-h test) than the SM/J-by-C57BL/6J hybrid males. The experimental-by-tester strain interaction is borderline signifi cant in females ( P = 0.051), with signifi cant interaction effects at 30 min and nearly signifi cant effects at 60 min. The pattern of effects in females is similar to that in males but at a reduced effect size. As expected, the AUC results correspond to those given by the multivariate tests of IPGTT time-specifi c glucose levels, although here the females show a signifi cant interaction effect ( P = 0.024) ( Fig. 4 ) .
The insulin response test (IRT) results were similar to those reported for the IPGTT ( Fig. 5 ), except that the three-way interaction was not quite signifi cant at the 5% level (Probability = 0.073). Therefore, results provided are for the sexes pooled. The MANOVA identifi es signifi cant experimental-by-tester strain interaction, with the effect of the Capn10 knockout being much stronger in the SM/J hybrids than in the LG/J hybrids. Neither serum insulin levels nor glucose levels at necropsy had signifi cant experimental-by-tester strain interaction, although the Capn10 knockout hybrids consistently had lower glucose levels than the wild-type C57BL/6J hybrids.
DISCUSSION
In our earlier QTL mapping study ( 1 ) utilizing the LGXSM recombinant inbred strains, we found a locus on chromosome 1 ( Adip1 ), between genome coordinates 92,584,545 and 128,413,910 bp, with effects on all four measured fat depots (reproductive, renal, mesenteric, and inguinal); body weight at necropsy; serum leptin and cholesterol levels; and tail length. Our new fi ndings confi rm our earlier QTL results in that most of the traits affected by Adip1 also failed to complement Capn10 , including the four fat depots, leptin, and body weight at necropsy. In addition, organ weights showed a failure to complement, with strong interactions for liver and heart weights and weaker interactions for kidney and spleen weights. We also found interactions for serum free fatty acids and Analyses were performed on both the raw and logarithmic scale, which produced similar results, so the raw scale is presented here for simplicity. Pairwise tests were also performed between the mutant and wild-type hybrids within the experimental strain for purposes of interpretation.
RESULTS
Means and standard deviations for all phenotypes in each of the hybrids, probabilities for differences between C57BL/6J wild-type and Capn10 knockouts when crossed to either SM/J or LG/J, and the probability of no experimental-by-tester strain interaction are provided in Table 2 . Analysis of the sum of the four fat pads indicates a signifi cant experimental-by-tester strain interaction. Hybrids between the SM/J strain and the mutant and wild-type tester strains were not different in their levels of adiposity ( Fig. 2 ) . In contrast, the LG/J strain hybrids had much heavier fat depots when crossed with the Capn10 knockout strain than with the wild-type C57BL/6J (2.32 g heavier, a 37% increase). Results are similar for the individual fat depots, with increases of 41%, 58%, 41%, and 19% for the reproductive, renal, mesenteric, and inguinal fat pads, respectively. Serum leptin showed a nearly signifi cant interaction ( P = 0.075) with the same pattern as that observed for the fat-pad weights. While a difference between mutant and wildtype was clear in the LG/J hybrids (50% difference; P = 3.1 × 10 Ϫ 5 ), the SM/J hybrids displayed a smaller (29%) but statistically signifi cant ( P = 0.024), difference between knockout and wild-type hybrids. Thus, leptin levels were higher in Capn10 knock-out than wild-type hybrids, but the crosses with LG/J were not quite significantly more different from one another than the crosses with SM/J.
Body and internal organ weights, including the heart, kidneys, liver, and spleen, all show the same hybrid phenotypic pattern as the fat pads, with signifi cant experimentalby-tester strain interactions. Percentage increase in body and organ weights between knockout and wild-type hybrids mated to LG/J ranged from a high of 34% for the liver to 18%, 16%, and 13% for body weight, heart weight, and spleen weight, with a low of 7% for the kidneys.
Serum free fatty acids ( P = 0.0084) and triglycerides ( P = 0.0068) showed signifi cant three-way interactions, indicating different effects in males and females. Sex-specifi c analyses indicated signifi cant interactions in females but not in males for FFA and TG. Patterns of hybrid differences for female FFA and TG are the same as noted above to complement in this study may be affected by other, nearby loci. Our statistical fi ndings clearly demonstrate that alleles from the SM/J and LG/J inbred mouse strains interact with the Capn10 knockout mutation on a C57BL/6J background. This result is most likely due to differences between triglycerides in females. No interaction was discovered for cholesterol levels. Even so, Capn10 hybrids had lower cholesterol levels than the C57BL/6J hybrids. Thus, there is strong congruence in phenotypes affected between the RI line QTL mapping and the QHCT experiments. Effects mapped to Adip1 in the RI lines that do not show failure Hybrids are SM/J × C57BL/6J (SM-B6); SM/J × Capn10 knockout (SM-C10); LG/J × C57BL/6J (LG-B6); and LG/J × Capn10 knockout (LG-C10). Probabilities are given for differences in means between SM-B6 and SM-C10 (Probability SM) and LG-B6 and LG-C10 (Probability LG), and the probability of experimental-by-tester strain interaction (Probability Int), which is the test for a failure to complement. Signifi cant probabilities are in boldface.
Abbreviations: AUC, area under the curve; IPGTT, intraperitoneal glucose tolerance test; IRT, insulin response test.
effect for the diabetes-related phenotypes, such as intraperitoneal glucose tolerance test (IPGTT) profi le, area under the curve (AUC), and insulin response test (IRT) profi le. For each of these phenotypes, the mutant-by-wildtype comparison is apparent in the crosses to SM/J but not in crosses to LG/J. Specifi cally, the wild-type-by-SM/J hybrids have a higher basal glucose level, higher AUC, and less complete recovery to baseline at 2 h than the Capn10 knockout-by-SM/J hybrids. The Capn10 knockout is protective against hyperglycemia when combined with the SM/J strain. The SM/J-by-C57BL/6J hybrids also respond poorly in the IRT, although this is primarily due to the higher fasting glucose levels in the SM/J-by-C57BL/6J hybrids. Again, the Capn10 knock-out protects against diabetes. It is also of interest that the interaction effect, while present in both sexes, is much stronger in the males than females. Thus, the effects of the Capn10 knockout are in opposite directions and occur in distinct backgrounds for obesity-and diabetes-related traits.
We also found sex-specifi c effects for levels of serum free fatty acid and triglyceride and for the IPGTT results. For the two serum components there is evidence that the effect of the Capn10 knockout is only apparent in females from the LG/J crosses. The IPGTT effects have the same pattern and are statistically signifi cant in both males and Fig. 2 . Total fat depot weight for the four hybrid classes produced in the QHCT. SM, the SM/J strain; LG, the LG/J strain; C10, the Capn10 knockout on a C57BL/6J strain background; B6, the wildtype C57BL/6J strain; NS, not signifi cant at the 10% level. Probability of no interaction between experimental and tester strains appears to the left of the two-headed arrow. Probability of no difference between B6 and C10 hybrids crossed to either the SM/J or LG/J strain appears above the horizontal line. Error bars represent one standard error around the group mean. QHCT, quantitative hybrid complementation test. Error bars placed at the top of each column represent plus and minus one standard error around the group means. the Capn10 alleles in the LG/J and SM/J genomes. We predict that sequence differences in or near the Capn10 locus are responsible for the observed quantitative failure to complement. These differences may be structural, as a result of coding differences between the LG/J and SM/J Capn10 alleles, or because of expression differences in some or all the tissues expressing Capn10 . It is also possible that the statistical interaction between LG/J and SM/J alleles and the Capn10 knockout may not localize to the Capn10 locus itself but be caused by epistatic interactions of Capn10 with other loci segregating between LG/J and SM/J. We feel this is less likely than a Capn10 -based difference between LG/J and SM/J because we previously mapped a QTL for the same traits that showed failure to complement to this region, and these QTL effects were not due to epistasis in the LGXSM RI strain study. However, further research is needed to eliminate the possibility of an epistatic source for the QHCT results. In either case, it is apparent that the Capn10 locus plays an important role in modulating obesity and diabetes in these mice.
The pattern of failure to complement over all phenotypes was complex. For most obesity traits, including the fat depots, body weight at necropsy, organ weights, and serum leptin, free fatty acids, and triglycerides, hybrids involving the LG/J strain showed a difference between Capn10 mutant and wild-type hybrids, whereas the mutantwild-type difference was absent in hybrids formed with the SM/J strain. Hence the Capn10 knockout leads to obesity, increased organ size, and increased serum leptin, free fatty acid, and triglyceride levels on a mixed C57BL/6J-by-LG/J hybrid background but not on a mixed C57BL/6J-by-SM/J hybrid background. Interestingly, this same combination of alleles and backgrounds has the opposite the LGXSM recombinant inbred strains ( 32 ) . Furthermore, Adip1 did not display sex-specifi c effects ( 1 ) . It appears that Capn10 does not contribute much to the sex-specifi c effects noted in the LG/J-by-SM/J cross, although there is at least some genetic variation for sexual dimorphism in serum component levels and glucose response at the Capn10 locus.
These differences in patterns of effects for obesity-and diabetes-related traits are consistent with our fi nding of a lack of correlation between obesity and diabetes phenotypes across the LGXSM RI strains ( 32 ) . While it is possible that a single molecular change could lead to both an increase in obesity and a decrease in diabetes (or vice versa), we must also consider the possibility that there are multiple molecular differences between LG/J and SM/J at the Capn10 locus with different molecular lesions leading to effects on different phenotypes. Other studies of CAPN10 in humans suggest that different single nucleotide polymorphisms (SNP s) are often associated with different phenotypes ( 33 ) . This may also be the case for the differential effects of LG/J and SM/J alleles.
In addition to the relevance of our fi ndings with regard to genetic differences between LG/J and SM/J inbred mouse strains, our results confi rm physiological effects of Capn10 variants on a wide variety of obesity-and diabetesrelated traits in mice. Obesity-related traits were strongly enhanced by the Capn10 knockout in a LG/J-by-C57BL/6J hybrid background, whereas hyperglycemic diabetesrelated traits were strongly reduced by the knockout in the SM/J-by-C57BL/6J hybrid background. In addition, the Capn10 knockout resulted in lower necropsy serum glucose and cholesterol levels in both backgrounds. This range of effects complements previous fi ndings regarding calpain-10's effects in various human populations. It also underscores the potential diffi culty in replicating statistical and physiological effects in different human populations. The knockout allele clearly has different effects in different crosses as most fi ndings in the LG/J-C57BL/6J contrasts are not replicated in the SM/J-C57BL/6J contrasts, and vice versa. Thus, most results are backgroundspecifi c. A similar phenomenon in human populations has the potential to mask the effects of calpain-10 alleles in some populations for some traits but not for others.
CONCLUSION
We have found a quantitative failure to complement at the Capn10 locus for obesity-and diabetes-related traits, supporting the hypothesis that this locus is, at least in part, responsible for Adip1 , a QTL detected in earlier mapping studies of the LG/J-by-SM/J cross ( 1 ). It is likely that single or multiple molecular differences in or near the Capn10 locus are responsible for obesity-and diabetes-related differences between the LG/J and SM/J inbred mouse strains. Our results confi rm the effects of calpain-10 on a variety of obesity-and diabetes-related traits previously reported in human populations and support the hypothesis that failure to replicate for some traits in human populations may be due to variation in genetic background effects. females in the SM/J crosses but are much stronger in males than in females. These sex differences in the effects of Capn10 are likely because of differences in the hormonal environment between the sexes and the consequences of these differences for Capn10 expression and function. However, it is noteworthy that Capn10 had similar effects in both sexes for all the other traits, including fat-pad weights, despite strong, ubiquitous sex-by-strain interactions reported for most of the traits analyzed here in Fig. 4 . AUC for males and females in the four hybrid groups in the QHCT. The AUC ( y axis) scale for males is twice that for females. SM, the SM/J strain; LG, the LG/J strain; C10, the Capn10 knockout on a C57BL/6J strain background; B6, the wild-type C57BL/6J strain. AUC, area under the curve; QHCT, quantitative hybrid complementation test. 
